Ryan Zimmerman
Stock Analyst at BTIG
(4.10)
# 475
Out of 5,072 analysts
219
Total ratings
54.05%
Success rate
10.76%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Reiterates: Buy | $91 | $76.25 | +19.34% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.28 | +368.75% | 6 | Nov 21, 2025 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $87 | $78.24 | +11.20% | 4 | Nov 21, 2025 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $7 → $9 | $5.39 | +66.98% | 8 | Nov 20, 2025 | |
| RCEL AVITA Medical | Upgrades: Neutral | n/a | $3.75 | - | 4 | Nov 20, 2025 | |
| SYK Stryker | Reiterates: Buy | $410 | $370.22 | +10.74% | 18 | Nov 14, 2025 | |
| MDAI Spectral AI | Maintains: Buy | $3.5 → $3 | $1.52 | +97.37% | 2 | Nov 12, 2025 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $2 → $1.5 | $0.62 | +141.20% | 3 | Nov 11, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Neutral | n/a | $2.93 | - | 6 | Nov 7, 2025 | |
| CARL Carlsmed | Maintains: Buy | $21 → $24 | $13.89 | +72.79% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $112 | $93.52 | +19.76% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $25.57 | +9.50% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $116 | $98.06 | +18.29% | 14 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.07 | +27.28% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $298.11 | +7.34% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $529 → $589 | $568.48 | +3.61% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.76 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $183.21 | +6.44% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $38.88 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $30.01 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $14.97 | +53.64% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $127.19 | +16.36% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.35 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.95 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $12.48 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $83.38 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.54 | +99.70% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.59 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.82 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $145.62 | +37.34% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $337.53 | +3.69% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $103.20 | +24.03% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $9.56 | +56.90% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.12 | +131.79% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.80 | +993.75% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $28.39 | - | 3 | Apr 2, 2020 |
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $76.25
Upside: +19.34%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.28
Upside: +368.75%
GE HealthCare Technologies
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $78.24
Upside: +11.20%
Organogenesis Holdings
Nov 20, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.39
Upside: +66.98%
AVITA Medical
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.75
Upside: -
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $370.22
Upside: +10.74%
Spectral AI
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.52
Upside: +97.37%
Xtant Medical Holdings
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.62
Upside: +141.20%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.93
Upside: -
Carlsmed
Nov 7, 2025
Maintains: Buy
Price Target: $21 → $24
Current: $13.89
Upside: +72.79%
Nov 5, 2025
Maintains: Buy
Price Target: $122 → $112
Current: $93.52
Upside: +19.76%
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $25.57
Upside: +9.50%
Oct 30, 2025
Maintains: Buy
Price Target: $104 → $116
Current: $98.06
Upside: +18.29%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.07
Upside: +27.28%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $298.11
Upside: +7.34%
Oct 22, 2025
Maintains: Buy
Price Target: $529 → $589
Current: $568.48
Upside: +3.61%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.76
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $183.21
Upside: +6.44%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $38.88
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $30.01
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.97
Upside: +53.64%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $127.19
Upside: +16.36%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.35
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.95
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.48
Upside: -
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $83.38
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.54
Upside: +99.70%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.59
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.82
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $145.62
Upside: +37.34%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $337.53
Upside: +3.69%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $103.20
Upside: +24.03%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $9.56
Upside: +56.90%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.12
Upside: +131.79%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.80
Upside: +993.75%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $28.39
Upside: -